CMP (Comprehensive Metabolic Panel) Interpretation by Decade of Life

What the CMP Measures and Why Age Context Matters

The CMP is a 14-analyte blood panel ordered more than 150 million times per year in the United States, according to CMS claims data. It covers four physiological domains: glucose metabolism, kidney filtration and waste clearance, liver synthetic and enzyme function, and mineral and electrolyte balance. Standard reference intervals are built from healthy adult populations pooled across all age groups, which means a 28-year-old and a 68-year-old are judged against nearly the same cutoffs.

That pooling creates blind spots. Creatinine climbs with muscle mass, then climbs again as filtration slows after 40. Fasting glucose rises by roughly 1-2 mg/dL per decade even in metabolically healthy adults. Alkaline phosphatase (ALP) spikes around puberty, normalizes in early adulthood, then rises again after menopause. A single reference range cannot capture this biology.

The 14 Analytes at a Glance

The panel includes: glucose, blood urea nitrogen (BUN), creatinine, estimated glomerular filtration rate (eGFR), BUN/creatinine ratio, sodium, potassium, chloride, carbon dioxide (CO2, a proxy for bicarbonate), calcium, total protein, albumin, total bilirubin, and one of two liver enzymes (alkaline phosphatase or ALT, depending on the ordering laboratory).

Fasting vs. Non-Fasting Results

Glucose and triglycerides (not on the CMP but often ordered together) shift with meal timing. For the most useful CMP, a 10-to-12-hour fast is preferred. A 2019 analysis published in JAMA Internal Medicine found that non-fasting glucose values up to 30 mg/dL higher than fasting equivalents are common, which can push an otherwise normal result into the pre-diabetic zone on a standard report.

CMP Reference Ranges vs. Optimal Ranges

"Reference range" and "optimal range" are not the same thing. Reference ranges are statistical constructs: they capture the middle 95% of a reference population. The National Academy of Clinical Biochemistry notes that a healthy individual will have at least one value outside the reference range in a 14-analyte panel purely by chance, because 0.95 to the power of 14 equals approximately 0.49.

Optimal ranges are narrower and derive from outcomes data. They ask: at what value is long-term risk lowest? For fasting glucose, population reference ranges allow values up to 99 mg/dL. Outcomes data from the Whitehall II cohort (N=10,308) showed that cardiovascular risk begins rising at fasting glucose above 85 mg/dL, well below the 100 mg/dL pre-diabetes threshold. That finding was replicated in a 2010 Diabetes Care analysis.

The Standard Lab Report Is a Floor, Not a Ceiling

Think of the reference range flag system as a smoke detector. It sounds when the house is on fire. Optimal-range thinking asks whether there is smoke before the alarm. Clinicians practicing preventive or longevity medicine use tighter targets that vary by age, sex, and body composition.

CMP by Decade: Your 20s

Glucose

Fasting glucose in a metabolically healthy 20-year-old should sit between 70 and 85 mg/dL. Values of 86-99 mg/dL are technically "normal" but represent early insulin resistance in this age group. A 2022 study in Diabetes Care (N=15,197) found that fasting glucose of 90-99 mg/dL in adults under 35 predicted type 2 diabetes within 10 years with a hazard ratio of 2.8.

Kidney Function

Creatinine in your 20s reflects muscle mass more than kidney health. Men typically run 0.9-1.2 mg/dL; women 0.6-0.9 mg/dL. EGFR should exceed 90 mL/min/1.73 m². A value of 60-89 at age 25 is worth investigating, not dismissing.

Liver Enzymes

ALT is the most useful liver screen. The American College of Gastroenterology defines the upper limit of normal as 29-33 U/L for men and 19-25 U/L for women, but longevity-oriented clinicians prefer ALT below 25 U/L in men and below 19 U/L in women during the 20s. Elevations in this decade often trace to alcohol, over-the-counter analgesics, or early non-alcoholic fatty liver disease (NAFLD).

Electrolytes and Minerals

Sodium should be 136-142 mEq/L. Potassium between 4.0 and 4.5 mEq/L sits in the lowest-mortality zone based on data from the large ARIC cohort. Calcium should be 9.0-10.2 mg/dL. Albumin at this age should be 4.3-5.0 g/dL; values below 4.0 in a 20-year-old suggest poor protein intake, chronic inflammation, or malabsorption.

CMP by Decade: Your 30s

Glucose and Insulin Resistance

The 30s are when metabolic drift often begins silently. Fasting glucose optimal target remains 70-85 mg/dL. A single fasting value of 92-99 mg/dL in this decade, combined with a waist circumference above 40 inches in men or 35 inches in women, meets the American Heart Association criteria for metabolic syndrome, even if the lab report reads "normal."

Liver Enzymes: The NAFLD Window

NAFLD prevalence in the United States reaches approximately 25% by the late 30s. A meta-analysis in the Journal of Hepatology (N=8.5 million participants) showed that NAFLD prevalence rises from roughly 20% in 20-to-29-year-olds to 39% in 40-to-49-year-olds. Catching ALT above 25 U/L in your 30s, even without symptoms, is a meaningful early signal.

Kidney Function

EGFR should still exceed 90 mL/min/1.73 m². BUN/creatinine ratio between 10 and 16 suggests adequate hydration and protein metabolism. A BUN/creatinine ratio above 20 in a 35-year-old without high protein intake suggests dehydration or early tubular dysfunction.

Electrolytes

CO2 (bicarbonate) of 24-28 mEq/L signals healthy acid-base balance. Research published in the Clinical Journal of the American Society of Nephrology found that serum bicarbonate below 22 mEq/L in adults without kidney disease independently predicts cardiovascular events, a finding that applies starting in the 30s.

CMP by Decade: Your 40s

The 40s are the decade where multiple CMP analytes begin shifting in tandem. GFR starts its age-related decline around age 40. Hormonal changes (declining testosterone in men, perimenopausal estrogen shifts in women) alter body composition and, with it, creatinine baselines. Liver fat accumulation accelerates. Insulin resistance deepens.

Glucose

Optimal fasting glucose target widens slightly to 70-90 mg/dL, acknowledging the physiological rise. Pre-diabetes (100-125 mg/dL) in a 45-year-old carries a 50% probability of progressing to type 2 diabetes within 10 years, per ADA Standards of Medical Care 2024.

eGFR and Creatinine

GFR declines at roughly 1 mL/min/1.73 m² per year after age 40 in healthy adults, per NephSAP and the MDRD study data. An eGFR of 80 at age 45 is meaningfully different from an eGFR of 80 at age 25. Creatinine in 40-something men with average muscle mass typically runs 0.95-1.25 mg/dL; women 0.65-0.95 mg/dL.

Albumin as a Metabolic Marker

Albumin below 4.0 g/dL in the 40s may reflect low-grade systemic inflammation even with a normal C-reactive protein. A 2017 analysis in the American Journal of Clinical Nutrition found that albumin below 4.0 g/dL in midlife adults predicted all-cause mortality over 20 years of follow-up, independent of kidney or liver disease.

ALP After 40

ALP in the 40s should remain below 80-90 U/L. Elevations here may signal early cholestasis, medications (statins, antiepileptics), or beginning bone turnover changes, particularly in women approaching perimenopause.

CMP by Decade: Your 50s

Glucose and Diabetes Screening

The American Diabetes Association recommends screening all adults for pre-diabetes starting at age 35, or earlier with risk factors. By the 50s, the prevalence of pre-diabetes in U.S. Adults reaches approximately 38%, per CDC surveillance data. An isolated fasting glucose of 95-99 mg/dL at age 55 combined with any metabolic syndrome criterion should prompt fasting insulin and HbA1c testing.

Kidney Function Thresholds

EGFR of 60-74 mL/min/1.73 m² at age 55 may still fall within the "normal aging" trajectory, but the KDIGO 2022 CKD guidelines specify that any eGFR below 60 requires two measurements at least 90 days apart and urine albumin-to-creatinine ratio (uACR) testing before a diagnosis of CKD Stage G3a is assigned.

Liver Enzymes and ALP Divergence in Women

ALP begins rising in women after menopause due to bone remodeling. An ALP of 90-110 U/L in a 52-year-old postmenopausal woman may be bone-derived, not hepatic. Fractionating ALP into liver versus bone isoenzymes resolves the ambiguity. The AASLD guidelines recommend fractionation when ALP exceeds 1.5 times the upper limit of normal.

Electrolytes: Sodium and Aging Kidneys

Mild hyponatremia (sodium 130-135 mEq/L) becomes more common in the 50s, particularly in individuals on thiazide diuretics or SSRIs. A 2013 BMJ meta-analysis found that even mild hyponatremia is associated with a 2.4-fold increase in fall risk in older adults, making sodium monitoring clinically consequential starting in this decade.

CMP by Decade: Your 60s and Beyond

Glucose: Tighter Management, Wider Range

Glycemic targets in adults over 65 are intentionally relaxed in some guidelines to reduce hypoglycemia risk. The American Geriatrics Society's Beers Criteria caution against targeting HbA1c below 7.5% in frail older adults. For the CMP glucose value specifically, fasting glucose of 85-95 mg/dL at age 70 requires context: Is this stable? Is there a downward trend suggesting early sarcopenia and reduced hepatic glucose output?

eGFR: When Age-Related Decline Becomes Pathological

By age 65, an eGFR of 55-65 mL/min/1.73 m² may reflect normal physiological aging rather than CKD if uACR is below 30 mg/g and there are no structural kidney abnormalities. The Berlin Initiative Study (BIS) developed age-adapted eGFR equations specifically for adults over 70, because the CKD-EPI equation overestimates GFR in elderly patients with reduced muscle mass.

Creatinine Paradox in Frail Adults

A creatinine of 0.7 mg/dL in a 72-year-old woman may mask an eGFR of only 48 mL/min/1.73 m² due to sarcopenia. Low creatinine in the elderly should not be reassuring. A 2016 paper in JAMA Internal Medicine highlighted that low muscle mass produces low serum creatinine, which artificially inflates calculated eGFR using standard equations.

Albumin as Frailty Marker

Albumin below 3.5 g/dL in adults over 65 is associated with frailty, malnutrition, and 12-month mortality in hospitalized patients. The ALBUMIN study group found that each 1 g/dL decline in serum albumin below 4.0 g/dL corresponded to a 137% increase in odds of 30-day mortality in acutely ill older adults. In the outpatient longevity context, albumin below 4.0 g/dL at any age over 60 warrants nutritional and inflammatory workup.

Electrolytes in the Seventh Decade and Beyond

Potassium dysregulation becomes clinically common after 65, particularly in patients on ACE inhibitors, ARBs, or potassium-sparing diuretics. Hyperkalemia above 5.5 mEq/L in this population requires medication review and dietary counseling. Hypokalemia below 3.5 mEq/L increases arrhythmia risk. The ACC/AHA heart failure guidelines target potassium of 4.0-5.0 mEq/L in patients with reduced ejection fraction.

Decade-by-Decade Optimal Target Summary

The table below consolidates optimal (not merely normal) targets by decade for the six most clinically actionable CMP analytes.

| Analyte | 20s | 30s | 40s | 50s | 60s+ | |---|---|---|---|---|---| | Fasting glucose (mg/dL) | 70-85 | 70-85 | 70-90 | 72-92 | 75-95 | | eGFR (mL/min/1.73 m²) | >90 | >90 | >80 | >70 | >60 (age-adj.) | | ALT (U/L) men | <25 | <25 | <30 | <33 | <35 | | ALT (U/L) women | <19 | <19 | <22 | <25 | <25 | | Albumin (g/dL) | 4.3-5.0 | 4.2-5.0 | 4.0-4.9 | 4.0-4.8 | >4.0 | | Potassium (mEq/L) | 4.0-4.5 | 4.0-4.5 | 4.0-4.5 | 4.0-4.5 | 4.0-5.0 |

How to Read a CMP Result That Looks "Normal" but Isn't

Standard lab reports flag values outside the reference range. They do not flag slow trends. A fasting glucose of 82, 87, 91, and 96 mg/dL over four annual draws tells a clear metabolic story. Each value alone is "normal." The trajectory is not.

Track Trends, Not Single Values

Request your raw numbers from each draw and plot them yourself. Most electronic health record patient portals allow trend views. The direction of change over 3-5 years is often more informative than any single result.

Sex-Specific Interpretation

Women generally run lower creatinine, lower ALT, and slightly lower eGFR than men at identical ages, driven by differences in muscle mass. NHANES-based reference intervals published in Clinical Chemistry confirm sex-specific normal ranges for creatinine: 0.6-1.1 mg/dL in women vs. 0.7-1.3 mg/dL in men across the adult lifespan.

Medications That Distort CMP Values

Several common drugs shift CMP analytes without indicating organ damage. Creatine supplementation raises creatinine. Trimethoprim blocks creatinine secretion, raising serum creatinine without affecting true GFR. Statins raise ALT in roughly 1-3% of patients. An FDA Drug Safety Communication confirmed that statins can cause mild, reversible ALT elevation that does not represent hepatotoxicity in most cases. Always review your medication list alongside lab results.

What Optimal CMP Values Signal for Longevity

Preventive and longevity medicine increasingly uses CMP analytes as aging biomarkers rather than disease screens. A 2021 prospective cohort analysis in Nature Aging (N=306,000) identified that a composite score incorporating glucose, creatinine, albumin, and ALP predicted biological age more accurately than chronological age, with each standard deviation of metabolic drift associated with a 22% increase in all-cause mortality.

The Albumin-Glucose Axis

Albumin and glucose together reflect two opposing metabolic pressures: anabolism and catabolism. High glucose with low albumin in midlife is a pattern associated with accelerated biological aging. Keeping fasting glucose below 85 mg/dL and albumin above 4.2 g/dL in adults under 50 sits at the center of most longevity-medicine protocols.

Kidney Function as Cardiovascular Predictor

EGFR is not just a kidney number. The CKD Prognosis Consortium meta-analysis (N=1.4 million) found that eGFR below 60 mL/min/1.73 m² doubles cardiovascular mortality risk independent of traditional risk factors. Monitoring eGFR trajectory decade by decade is cardiovascular risk management, not just nephrology.